milk thistle silymarin low dose
Selected indexed studies
- Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. (Integr Cancer Ther, 2007) [PMID:17548790]
- Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis. (Biomed Res Int, 2013) [PMID:23781510]
- Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. (Phytother Res, 2019) [PMID:31069872]
_Worker-drafted node — pending editorial review._
Connections
milk thistle silymarin low dose helps
Sources
- Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. (2019) pubmed
- Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. (2007) pubmed
- Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis. (2013) pubmed
- Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells. (2011) pubmed